GlassScriptPhysician profile
Joseph R Gaudio
NPI 1427260173
$2,481.43
in general payments reported to CMS, 2019-2025
15 companies · $250 in 2025
The $250 reported for 2025 was more than what 84% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2021: $1,239 · 2023: $421 · 2024: $360 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,031.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $1,309.72 | 2021-2024 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Medtronic, INC. | $329.82 | 2021-2023 | Signia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $297.16 | 2024-2025 | Xifaxan |
| Covidien LP | $147.04 | 2019 | |
| Intuitive Surgical, INC. | $95.65 | 2021 | |
| Ironwood Pharmaceuticals, INC | $46.43 | 2024 | |
| Merck Sharp & Dohme LLC | $43.84 | 2024 | Dificid |
| Apollo Endosurgery US INC | $37.92 | 2019-2021 | |
| Eisai INC. | $29.12 | 2019 | |
| Baxter Healthcare | $27.94 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Ardelyx, INC. | $27.47 | 2025 | Ibsrela |
| Celltrion USA INC. | $27.44 | 2024 | Vegzelma |
| Takeda Pharmaceuticals U.S.A., INC. | $24.79 | 2024 | Entyvio |
| Olympus America INC. | $20.47 | 2021 | |
| Novo Nordisk INC | $16.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Gaudio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.